Beam Therapeutics (NASDAQ: BEAM) is pioneering the use of CRISPR base editing to develop precision genetic medicines that treat disease, one letter at a time.
Sector: Life Sciences
Tempest Therapeutics
Tempest Therapeutics (Nasdaq: TPST) is a development-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways.
NFlection Therapeutics
NFlection Therapeutics is a biopharmaceutical company focused on the development of therapies for Neurofibromatosis 1 (NF1), and other disorders.
Plasmagen Biosciences
Plasmagen is an Indian biopharma company that specializing exclusively in Plasma Protein Therapy.
Curegenix
Curegenix is a Chinese leader in discovery and development of novel drugs in stem cell related diseases.
Cytek Biosciences
Cytek Biosciences Inc. (NASDAQ: CTBK) is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capabilities.
Indalo Therapeutics
Indalo Therapeutics, a preclinical biotechnology company dedicated to developing therapies for fibrosis, is formed with an experienced team, strong IP, and robust portfolio of drug candidates.
Avalyn Pharmaceuticals
Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, at the level of C3, the central protein in the complement cascade.
Zenflow
Zenflow is a medical device company developing the Spring Implant for patients with benign prostate hyperplasia (BPH).